Imugene: A beautiful pairing in the fight against cancer
Listen to ASX-listed Imugene MD, Leslie Chong talk to Matt Birney on the 6PR Bulls N’ Bears Report about the company’s new worldwide license to develop and commercialise an innovative treatment for solid cancerous tumours developed by a renowned US cancer research centre.